The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape
Open accessAbstract
Liposomes were the first nanoscale drug to be approved for clinical use in 1995. Since then, the technology has grown considerably, and pioneering recent work in liposome-based delivery systems has brought about remarkable developments with significant clinical implications. This includes long-circulating liposomes, stimuli-responsive liposomes, nebulized liposomes, elastic liposomes for topical, oral and transdermal delivery and covalent lipid-drug complexes for improved drug plasma membrane crossing and targeting to specific organelles. While the regulatory bodies' opinion on liposomes is well-documented, current guidance that address new delivery systems are not. This review describes, in depth, the current state-of-the-art of these new liposomal delivery systems and provides a critical overview of the current regulatory landscape surrounding commercialization efforts of higher-level complexity systems, the expected requirements and the hurdles faced by companies seeking to bring novel liposome-based systems for clinical use to market.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · cited 2×
“Since first being described by English hematologist Alec Bangham in 1961 (Bangham et al., 1965), artificial lipid vesicles (also called liposomes) have been recognized and extensively used as delivery vehicles for pharmaceuticals (Karmali & Chaudhuri, 2007), as chemical microreactors (Deepthi & Kavitha,, 2014; Lemière…”
BackgroundAdvances and Challenges of Liposome Assisted Drug Delivery
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,632
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Touitou, E., Dayan, N., Bergelson, L., Godin, B., & Eliaz, M. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00222-9 · Cited by 1,345
Liposomal Drug Delivery Systems: An Update Review
Samad, A., Sultana, Y., & Aqil, M. (2007) · Current Drug Delivery · doi:10.2174/156720107782151269 · Cited by 906
Yeh, M.-K., Chang, H.-I., & Cheng, M.-Y. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s26766 · Cited by 801
Targeted pharmaceutical nanocarriers for cancer therapy and imaging
Torchilin, V. P. (2007) · The AAPS Journal · doi:10.1208/aapsj0902015 · Cited by 762
Structure of the skin barrier and its modulation by vesicular formulations
Bouwstra, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(02)00028-0 · Cited by 635
Andresen, T. L., Jensen, S. S., & Jørgensen, K. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.12.001 · Cited by 580
Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example
Torchilin, V. P. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_1 · Cited by 573
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy
Parhi, P., Mohanty, C., & Sahoo, S. K. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.010 · Cited by 573
Ahsan, F. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00549-1 · Cited by 570 · cited 1×
“For such active targeting applications, negatively charged lipids such as phosphatidylserine (PS) and phosphatidylglycerol (PG) are preferentially used (Ahsan et al., 2002).”
Lipid vesicles for skin delivery of drugs: Reviewing three decades of research
Elsayed, M. M. A., Abdallah, O. Y., Naggar, V. F., & Khalafallah, N. M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.005 · Cited by 537
Zhu, L., Kate, P., & Torchilin, V. P. (2012) · ACS Nano · doi:10.1021/nn300524f · Cited by 489
Liposome-based drug delivery in breast cancer treatment
Park, J. W. (2002) · Breast Cancer Research · doi:10.1186/bcr432 · Cited by 469
Enhancement of transdermal drug delivery via synergistic action of chemicals
Karande, P., & Mitragotri, S. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.08.015 · Cited by 399
Mohammed, A. R., Weston, N., Coombes, A. G. A., Fitzgerald, M., & Perrie, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.010 · Cited by 386
Deformable liposomes and ethosomes: Mechanism of enhanced skin delivery
Elsayed, M. M. A., Abdallah, O. Y., Naggar, V. F., & Khalafallah, N. M. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.05.027 · Cited by 383
Challenges in Development of Targeted Liposomal Therapeutics
Sawant, R. R., & Torchilin, V. P. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9330-0 · Cited by 379
Therapeutic and cosmeceutical potential of ethosomes: An overview
Verma, P., & Pathak, K. (2010) · Journal of Advanced Pharmaceutical Technology & Research · doi:10.4103/0110-5558.72415 · Cited by 357
Safety evaluation of topical applications of ethanol on the skin and inside the oral cavity
Lachenmeier, D. W. (2008) · Journal of Occupational Medicine and Toxicology · doi:10.1186/1745-6673-3-26 · Cited by 331
Surface Engineering of Liposomes for Stealth Behavior
Nag, O., & Awasthi, V. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5040542 · Cited by 322
In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizón, A., Horowitz, A. T., Goren, D., Tzemach, D., Shmeeda, H., & Zalipsky, S. (2003) · PubMed · Cited by 295
Karmali, P. P., & Chaudhuri, A. (2007) · Medicinal Research Reviews · doi:10.1002/med.20090 · Cited by 289
Allen, T. M., Brandeis, E., Hansen, C. B., Kao, G. Y., & Zalipsky, S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00085-h · Cited by 288
The use of lipid-based nanocarriers for targeted pain therapies
Hua, S., & Wu, S. Y. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00143 · Cited by 268
Sun, G. Y., & Sun, A. Y. (1985) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1985.tb05543.x · Cited by 227
Expert opinion: Responsive polymer nanoparticles in cancer therapy
Liechty, W. B., & Peppas, N. A. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.08.004 · Cited by 226
Zalipsky, S., Qazen, M., Walker, J. A., Mullah, N., Quinn, Y. P., & Huang, S. K. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990031n · Cited by 198
Fahr, A., Hoogevest, P. V., May, S., Bergstrand, N., & S. Leigh, M. L. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.05.012 · Cited by 189
Wang, Y., Su, H.-H., Yang, Y., Hu, Y., Zhang, L., Blancafort, P., & Huang, L. (2013) · Molecular Therapy · doi:10.1038/mt.2012.250 · Cited by 183
Liposome-Anchored Vascular Endothelial Growth Factor Aptamers
Willis, M. C., Collins, B., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C., Kellogg, E., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980002x · Cited by 181
Pharmacosomes: the lipid-based new drug delivery system
Semalty, A., Semalty, M., Rawat, B., Singh, D., & Rawat, M. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902967607 · Cited by 163
Pasut, G., Paolino, D., Celia, C., Mero, A., Joseph, A. S., Wolfram, J., Cosco, D., Schiavon, O., Shen, H., & Fresta, M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.008 · Cited by 158
Layer-by-layer cell membrane assembly
Matosevic, S., & Paegel, B. M. (2013) · Nature Chemistry · doi:10.1038/nchem.1765 · Cited by 158
Self-citationLipids, curvature, and nano‐medicine
Mouritsen, O. G. (2011) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201100050 · Cited by 157
Trigger release liposome systems: local and remote controlled delivery?
Bibi, S., Lattmann, E., Mohammed, A. R., & Perrie, Y. (2011) · Journal of Microencapsulation · doi:10.3109/02652048.2011.646330 · Cited by 151
Liposome-Anchored Vascular Endothelial Growth Factor Aptamers
Willis, M. C., Collins, B. T., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C. J., Kellogg, E. A., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980200o · Cited by 146
Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes
Lee, E. H., Kim, A., Oh, Y., & Kim, C. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.02.020 · Cited by 143
Chang, D.-K., Lin, C., Wu, C., & Wu, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004171 · Cited by 137
Liposomes as Drug Delivery Systems for The Treatment of TB
Pinheiro, M., Lúcio, M., Lima, J. L. F. C., & Reis, S. (2011) · Nanomedicine · doi:10.2217/nnm.11.122 · Cited by 125
Lee, J. S., Ankoné, M. J. K., Pieters, E. H. E., Schiffelers, R. M., Hennink, W. E., & Feijén, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.028 · Cited by 118
Characterization of Nebulized Liposomal Amikacin (Arikace ™ ) as a Function of Droplet Size
Li, Z., Zhang, Y., Wurtz, W., Lee, J. K., Malinin, V., Durwas-Krishnan, S., Meers, P. R., & Perkins, W. R. (2008) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2008.0686 · Cited by 112
Nonviral Gene Delivery to Mesenchymal Stem Cells Using Cationic Liposomes for Gene and Cell Therapy
Madeira, C. G., Mendes, R. D., Ribeiro, S. C., Boura, J. S., Aires-Barros, M. R., da Silva, C. L., & Cabral, J. M. S. (2010) · BioMed Research International · doi:10.1155/2010/735349 · Cited by 108
Feldman, E. J., Kolitz, J. E., Trang, J. M., Liboiron, B. D., Swenson, C. E., Chiarella, M. T., Mayer, L. D., Louie, A. C., & Lancet, J. E. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.07.006 · Cited by 103
Phototriggerable Liposomes: Current Research and Future Perspectives
Puri, A. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics6010001 · Cited by 94
The Potential of Liposomes in Oral Drug Delivery
Rogers, J. A., & Anderson, K. E. (1998) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v15.i5.10 · Cited by 94
Nanoparticles Do Not Penetrate Human Skin—A Theoretical Perspective
Watkinson, A. C., Bunge, A. L., Hadgraft, J., & Lane, M. E. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1073-9 · Cited by 92
Biswas, S., Dodwadkar, N. S., Sawant, R. R., Koshkaryev, A., & Torchilin, V. P. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2010.536983 · Cited by 88
Vujašković, Ž., Kim, D. W., Jones, E. L., Lan, L., McCall, L. M., Dewhirst, M. W., Craciunescu, O. I., Stauffer, P. R., Liotcheva, V. B., Warner, A. B., et al. (2010) · International Journal of Hyperthermia · doi:10.3109/02656731003639364 · Cited by 84
Shaikh, I. M., Tan, K.-B., Chaudhury, A., Liu, Y., Tan, B.-J., Tan, B. M. J., & Chiu, G. N. C. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.025 · Cited by 83
Yudina, A., de Smet, M., Lepetit‐Coiffé, M., Langereis, S., Ruijssevelt, L. V., Смирнов, П. В., Bouchaud, V., Voisin, P. J., Grüll, H., & MOONEN, C. T. W. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.006 · Cited by 79
Matosevic, S. (2012) · BioEssays · doi:10.1002/bies.201200105 · Cited by 78
Self-citationKoshkina, N. V., Gilbert, B. E., Waldrep, J. C., Seryshev, A. B., & Knight, V. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050966 · Cited by 76
Liposomes as sustained release system for human interferon-γ: biopharmaceutical aspects
van Slooten, M. L., Boerman, O. C., Romøren, K., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00174-8 · Cited by 74
Zheng, C.-Y., Ma, C., Bai, E., Yang, K., & Xu, R. (2015) · PubMed Central · Cited by 60
Tseng, W., & Huang, L. (1998) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(98)00054-6 · Cited by 42
Sharma, V. K., Sarwa, K. K., & Mazumder, B. (2013) · Journal of Liposome Research · doi:10.3109/08982104.2013.847956 · Cited by 39
Tang, Y., Gan, X., Cheheltani, R., Curran, E. H., Lamberti, G., Krynska, B., Kiani, M. F., & Wang, B. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.06.001 · Cited by 37
Cell-sized liposomes that mimic cell motility and the cell cortex
Lemiere, J. P. C., Carvalho, K., & Sykes, C. (2015) · Methods in cell biology · doi:10.1016/bs.mcb.2015.01.013 · Cited by 35
Targeting Liposomes Toward Novel Pediatric Anticancer Therapeutics
Federman, N. C., & Denny, C. T. (2010) · Pediatric Research · doi:10.1203/pdr.0b013e3181d601c5 · Cited by 35
Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature
Sakurai, Y., Kajimoto, K., & Harashima, H. (2015) · Biomaterials Science · doi:10.1039/c5bm00113g · Cited by 20
Liposomal Drug Delivery System-A Review
Deepthi, V., & Kavitha, A. N. (2014) · Rajiv Gandhi University of Health Sciences Journal of Pharmaceutical Sciences · doi:10.5530/rjps.2014.2.3 · Cited by 14
Xu, D., Zhang, Q., Feng, X., Xu, X., & Liang, W. (2007) · Die Pharmazie · doi:10.31083/ph.2007.4.6225 · Cited by 11
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., & Shao, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00193 · Cited by 1,451
Design of liposomes as drug delivery system for therapeutic applications
Guimarães, D., Cavaco-Paulo, A., & Nogueira, E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120571 · Cited by 1,196
Liposomes: Advancements and innovation in the manufacturing process
Shah, S., Dhawan, V., Holm, R., Nagarsenker, M. S., & Perrie, Y. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.002 · Cited by 745
Metadata
- Authors
- Zylberberg, C., & Matosevic, S.
- Venue
- Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2016-05-05
- Volume
- 23
- Issue
- 9
- Pages
- 3319-3329
- ISSN
- 1071-7544 (ISSN-L)
- 1521-0464
- OpenAlex
- W2388009875
- Cited by
- 627
- References
- 65
- FWCI
- 16.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.